Mirhoseini M, Shelgikar S, Cayton M M
Department of Cardiothoracic Surgery, St. Luke's Hospital, Milwaukee, WI.
Ann Thorac Surg. 1988 Apr;45(4):415-20. doi: 10.1016/s0003-4975(98)90015-7.
The concept of direct revascularization of ischemic myocardium by transmural left ventricular conduits has been investigated by several researchers. Early success was followed by closure of the pathways by fibrosis and scarring caused by mechanical trauma. The CO2 laser was examined as an alternative method of creating channels. Early experiments supported the hypothesis that laser channels would perfuse ischemic areas and would remain patent. Histological examination showed patent, endothelialized channels more than 2 years following operation in the experimental model. A clinical protocol was designed to assess the results of laser revascularization in a series of 12 patients. Patients selected were candidates for bypass grafting, but because of the coronary artery pathology involved, it was thought bypass grafting alone would result in incomplete revascularization. None of the 12 patients have died. Follow-up ranges from 3 to 32 months. Postoperative thallium stress tests and left ventriculography indicate that channels have remained patent and that they perfuse the myocardium. Direct laser revascularization of the myocardium may offer a viable adjunct in the treatment of ischemic heart disease.
几位研究人员对经壁左心室导管实现缺血心肌直接血运重建的概念进行了研究。早期虽取得成功,但随后这些通路因机械创伤导致的纤维化和瘢痕形成而闭塞。二氧化碳激光被作为创建通道的一种替代方法进行研究。早期实验支持了这样的假说,即激光通道会灌注缺血区域并保持通畅。组织学检查显示,在实验模型中,术后两年多通道依然通畅且有内皮化。设计了一项临床方案来评估12例患者接受激光血运重建的结果。入选患者均为旁路移植术的候选对象,但由于涉及冠状动脉病变,认为仅行旁路移植术会导致血运重建不完全。12例患者均未死亡。随访时间为3至32个月。术后铊负荷试验和左心室造影表明通道依然通畅且能灌注心肌。心肌直接激光血运重建可能为缺血性心脏病的治疗提供一种可行的辅助手段。